Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.66 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14896741 | 1.00 | TSHR (0.71) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL16002431 | 1.00 | TSHR (0.71) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL29366942 | 1.00 | TSHR (0.71) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL10922740 | 0.91 | ADRB2 (0.71) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL18654313 | 0.90 | TSHR (0.58) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL3671328 | 0.87 | MAPK1 (0.83) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL14173781 | 0.87 | TSHR (0.58) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL1496742 | 0.86 | ADRB2 (0.66) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL1496524 | 0.85 | ADRB2 (0.64) | TSHRMAPK1ADRB2ADRB1KMT2A | |
| SCHEMBL1496641 | 0.85 | ADRB2 (0.64) | TSHRMAPK1ADRB2ADRB1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112996489-A | Sol-gel composition | 株式会社爱茉莉太平洋 | 2021-06-18 | — | — | CN | claimed |
| US-20260103839-A1 | Method For Producing Transfer Medium And Transfer Recording Method | SEIKO EPSON CORP (JP) | 2026-04-16 | — | — | US | disclosed |
| EP-4112695-B1 | TREATMENT LIQUID COMPOSITION, SET OF INK JET INK COMPOSITION AND TREATMENT LIQUID COMPOSITION, AND TREATMENT METHOD | SEIKO EPSON CORP (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20250361676-A1 | INKJET TEXTILE PRINTING METHOD | SAKATA INX CORP (JP) | 2025-11-27 | — | — | US | disclosed |
| US-20250303772-A1 | Method For Producing Transfer Medium | SEIKO EPSON CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| US-20250304814-A1 | Treatment Liquid And Recording Method | SEIKO EPSON CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4585658-A1 | INKJET-TEXTILE PRINTING METHOD | Sakata INX Corporation (JP) | 2025-07-16 | — | — | EP | disclosed |
| US-12305052-B2 | Ink set, recording method, and recording device | SEIKO EPSON CORPORATION (JP) | 2025-05-20 | — | — | US | disclosed |
| US-20250128533-A1 | Transfer Recording Method | SEIKO EPSON CORPORATION (JP) | 2025-04-24 | — | — | US | disclosed |
| US-20250059391-A1 | Recording Method And Ink Set | SEIKO EPSON CORPORATION (JP) | 2025-02-20 | — | — | US | disclosed |
| WO-2010003048-A1 | BENZIMIDAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRTRIS PHARMACEUTICALS, INC. (US) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009146358-A1 | IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRTRIS PHARMACEUTICALS, INC. (US) | 2009-12-03 | — | — | WO | disclosed |
| WO-2009134973-A1 | QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS | SIRTRIS PHARMACEUTICALS, INC. (US) | 2009-11-05 | — | — | WO | disclosed |
| EP-1380342-B1 | COMPLEX CATALYST, PROCESS FOR PRODUCING THE COMPLEX CATALYST, AND PROCESS FOR PRODUCING ALCOHOL DERIVATIVE WITH THE COMPLEX CATALYST | SUMITOMO CHEMICAL CO (JP) | 2009-07-01 | — | — | EP | disclosed |
| US-20090012330-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1982972-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1982973-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-10-22 | — | — | EP | disclosed |
| US-6995110-B2 | Complex catalyst, process for producing the complex catalyst, and process for producing alcohol derivative with the complex catalyst | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-02-07 | — | — | US | disclosed |
| US-20040077487-A1 | Complex catalyst, process for producing the complex catalyst, and process for producing alchohol derivative with the complex catalyst | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1380342-A1 | COMPLEX CATALYST, PROCESS FOR PRODUCING THE COMPLEX CATALYST, AND PROCESS FOR PRODUCING ALCOHOL DERIVATIVE WITH THE COMPLEX CATALYST | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012330-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | ADH1A, ADH1C, ADH5 | TSHR 1213/4885MAPK1 1367/4885ADRB2 1220/4885 |
| US-20260103839-A1 | Method For Producing Transfer Medium And Transfer Recording Method | ICAM1, TRRAP, ACTN4 | TSHR 4014/4885MAPK1 172/4885ADRB2 1734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.